DALLAS: Researchers at the Human Microbiology Institute (HMI) have uncovered a potential new Alzheimer’s treatment that significantly reversed the late-stage effects of the debilitating neurodegenerative disease.

The results detail the promising results that the research duo of Victor and George Tetz had in treating a Read More »

MIAMI: The Queen has opened Cardiff University’s new £44m Brain Research Imaging Centre (Cubric).

It has been called the “most significant advance in brain imaging in Europe in the last 10 years”.

The Maindy Park building brings together four hi-tech scanners under one roof.

One Read More »

NEW YORK: Alzheimer’s disease (AD) is a devastating condition with no known effective treatment. The disease is characterized by memory loss as well as impaired locomotor ability, reasoning, and judgment. Emerging evidence suggests that the innate immune response plays a major role in the pathogenesis of Read More »

NEW YORK: Drugs to treat cancer and Alzheimer’s disease usually target the active sites of specific protein molecules sustaining the disease. Traditional drug design views proteins as rigid 3-D objects with active sites consisting of surface-accessible “pockets” with a specific, well-defined structure. Traditional drug design involves Read More »